- Home
- FORA vs MDAI Comparison
FORA vs MDAI Comparison
Compare FORA & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FORA | MDAI |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.3M | 77.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FORA | MDAI |
|---|---|---|
| Price | $2.16 | $1.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 58.1K | ★ 969.9K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,256,919.00 | N/A |
| Revenue This Year | $8.44 | N/A |
| Revenue Next Year | N/A | $23.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 50.13 | N/A |
| 52 Week Low | $1.64 | $1.18 |
| 52 Week High | $2.71 | $3.21 |
Technical Indicators
Market Signals| Indicator | FORA | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 64.06 | 42.40 |
| Support Level | $2.05 | $1.78 |
| Resistance Level | $2.20 | $2.89 |
| Average True Range (ATR) | 0.01 | 0.26 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 66.67 | 1.94 |
Price Performance
Historical ComparisonAbout FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.